GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmuCell Corp (FRA:IUL) » Definitions » Issuance of Debt

ImmuCell (FRA:IUL) Issuance of Debt : €3.75 Mil (TTM As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is ImmuCell Issuance of Debt?

ImmuCell's Issuance of Debt for the three months ended in Mar. 2024 was €0.00 Mil.

ImmuCell's Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2024 was €3.75 Mil.

ImmuCell Issuance of Debt Historical Data

The historical data trend for ImmuCell's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmuCell Issuance of Debt Chart

ImmuCell Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 9.48 0.35 1.89 4.59

ImmuCell Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.87 - 3.75 - -

ImmuCell Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €3.75 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ImmuCell Issuance of Debt Related Terms

Thank you for viewing the detailed overview of ImmuCell's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

ImmuCell (FRA:IUL) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmuCell Corp (FRA:IUL) » Definitions » Issuance of Debt
Comparable Companies
OCUP CTCX XLO APLM SABS MRKR NXTC PMN NTRB CARA OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB XBRU:ARGX BNTX
Traded in Other Exchanges
ICCC:USA
Address
56 Evergreen Drive, Portland, ME, USA, 04103
Website
https://www.immucell.com
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The firm has developed products that provide immediate immunity to newborn dairy and beef cattle and is developing product line extensions of its existing products that address mastitis. Its lead product, First Defense, is manufactured to prevent scours in newborn calves. It has two segments Scours and Mastitis. The company generates the majority of its revenue from the United States.

ImmuCell (FRA:IUL) Headlines

No Headlines